These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21177715)

  • 21. Learning from the voiceless.
    Huniche L
    New Genet Soc; 2003 Dec; 22(3):257-96. PubMed ID: 15115026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intended use of predictive testing by those at risk for Huntington disease.
    Meissen GJ; Berchek RL
    Am J Med Genet; 1987 Feb; 26(2):283-93. PubMed ID: 2949612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
    Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):47-55. PubMed ID: 18189288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
    Huggins M; Bloch M; Wiggins S; Adam S; Suchowersky O; Trew M; Klimek M; Greenberg CR; Eleff M; Thompson LP
    Am J Med Genet; 1992 Feb; 42(4):508-15. PubMed ID: 1535178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seeking serenity: living with HIV/AIDS in rural Western Canada.
    Groft JN; Robinson Vollman A
    Rural Remote Health; 2007; 7(2):677. PubMed ID: 17516839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the decision to take the predictive test for Huntington disease.
    Meissen GJ; Mastromauro CA; Kiely DK; McNamara DS; Myers RH
    Am J Med Genet; 1991 Jun; 39(4):404-10. PubMed ID: 1678928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic susceptibility testing from a stress and coping perspective.
    Gooding HC; Organista K; Burack J; Biesecker BB
    Soc Sci Med; 2006 Apr; 62(8):1880-90. PubMed ID: 16198036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring supportive care for individuals affected by Huntington disease and their family caregivers in a community setting.
    Soltysiak B; Gardiner P; Skirton H
    J Clin Nurs; 2008 Apr; 17(7B):226-34. PubMed ID: 18578798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
    Tibben A; Frets PG; van de Kamp JJ; Niermeijer MF; Vegtervan der Vlis M; Roos RA; Rooymans HG; van Ommen GJ; Verhage F
    Am J Med Genet; 1993 Jul; 48(2):103-11. PubMed ID: 8362926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "I'm scared of being like mum": The Experience of Adolescents Living in Families with Huntington Disease.
    Mand CM; Gillam L; Duncan RE; Delatycki MB
    J Huntingtons Dis; 2015; 4(3):209-17. PubMed ID: 26443924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological distress in the 5-year period after predictive testing for Huntington's disease.
    Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
    Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disrupted lives and threats to identity: the experiences of people with colorectal cancer within the first year following diagnosis.
    Hubbard G; Kidd L; Kearney N
    Health (London); 2010 Mar; 14(2):131-46. PubMed ID: 20164162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The meaning of risk to first degree relatives of women with breast cancer.
    Sheinfeld Gorin S; Albert SM
    Women Health; 2003; 37(3):97-117. PubMed ID: 12839310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychological costs and benefits of predictive testing for Huntington's disease.
    Codori AM; Brandt J
    Am J Med Genet; 1994 Sep; 54(3):174-84. PubMed ID: 7810575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personal factors associated with reported benefits of Huntington disease family history or genetic testing.
    Williams JK; Erwin C; Juhl A; Mills J; Brossman B; Paulsen JS;
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):629-36. PubMed ID: 20722493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
    Quaid KA; Wesson MK
    Am J Med Genet; 1995 May; 57(1):46-51. PubMed ID: 7645597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for genetic testing in Huntington disease: three years of experience in Minnesota.
    Nance MA; Leroy BS; Orr HT; Parker T; Rich SS; Heston LL
    Am J Med Genet; 1991 Sep; 40(4):518-22. PubMed ID: 1836107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.